Market Overview:
The global radiopharmaceuticals market reached a value of US$ 4.9 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 7.2 Billion by 2027, exhibiting a CAGR of 6.76% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Radiopharmaceuticals are unique formulations comprising radioisotopes that are used in clinical areas for diagnosis and therapy. These medicinal drugs are administered by a radio pharmacist, a medical professional who specializes in nuclear medicine. They are taken in the form of a pill or injected into a vein or cavity of the patient’s body. Once they reach the targeted location, they release radioactive agents to destroy the tumor cells. As a result, radiopharmaceuticals are used to treat thyroid, brain, lymphoma and other types of cancer that have spread to the bones.
Radiopharmaceuticals Market Trends:
The increasing prevalence of cancerous diseases on account of the rising aging population and unhealthy dietary patterns represent the key factors contributing to the growing use of radiopharmaceuticals across the globe. Apart from this, the escalating number of diagnostic centers is also supporting the market. Moreover, the rising number of oncologists that are suggesting disease-targeted cancer therapy, which utilizes drugs to target specific proteins and genes involved in the development of cancer cells, are positively influencing the overall sales. Furthermore, the use of radiolabeled peptides and monoclonal antibodies for the diagnosis and treatment of cancerous tumors, along with rising healthcare expenditures, is strengthening the market growth. Other major factors anticipated to propel the growth of the market include the increasing use of radiopharmaceuticals by oncologists to track radioactivity throughout the body and determine the presence of cancer cells and the increasing shift towards positron emission tomography (PET) and single-photon emission computerized tomography (SPECT) scans.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global radiopharmaceuticals market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product type, application and end use.
Breakup by Product Type:
- Diagnostic Nuclear Medicine
- Therapeutic Nuclear Medicine
Breakup by Application:
- Oncology
- Cardiology
- Neurology
- Endocrinology
- Others
Breakup by End Use:
- Hospitals and Clinics
- Research Institutes
- Diagnostic Centers
Breakup by Region:
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Advanced Accelerator Applications (Novartis AG), Bayer AG, Bracco S.p.A., Cardinal Health Inc., Curium Pharma, General Electric Company, IBA RadioPharma Solutions, Jubilant Pharma Limited, Lantheus Medical Imaging Inc, Nordion Inc. (Sotera Health), NTP Radioisotopes SOC Ltd, PharmaLogic Holdings Corp. and Siemens AG.
Report Coverage:
| Report Features |
Details |
|---|
| Base Year of the Analysis |
2021 |
| Historical Period |
2016-2021 |
| Forecast Period |
2022-2027 |
| Units |
US$ Billion |
| Segment Coverage |
Product Type, Application, End Use, Region |
| Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
| Companies Covered |
Advanced Accelerator Applications (Novartis AG), Bayer AG, Bracco S.p.A., Cardinal Health Inc., Curium Pharma, General Electric Company, IBA RadioPharma Solutions, Jubilant Pharma Limited, Lantheus Medical Imaging Inc, Nordion Inc. (Sotera Health), NTP Radioisotopes SOC Ltd, PharmaLogic Holdings Corp. and Siemens AG |
| Customization Scope |
10% Free Customization |
| Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499 |
| Post-Sale Analyst Support |
10-12 Weeks |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global radiopharmaceuticals market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global radiopharmaceuticals market?
- What are the key regional markets?
- What is the breakup of the market based on the product type?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end use?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global radiopharmaceuticals market and who are the key players?
- What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Radiopharmaceuticals Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product Type
6.1 Diagnostic Nuclear Medicine
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Therapeutic Nuclear Medicine
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Application
7.1 Oncology
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Cardiology
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Neurology
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Endocrinology
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by End Use
8.1 Hospitals and Clinics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Research Institutes
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Diagnostic Centers
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Advanced Accelerator Applications (Novartis AG)
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.2 Bayer AG
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Bracco S.p.A.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 SWOT Analysis
14.3.4 Cardinal Health Inc.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Curium Pharma
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 General Electric Company
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 IBA RadioPharma Solutions
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Jubilant Pharma Limited
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 Lantheus Medical Imaging Inc
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.10 Nordion Inc. (Sotera Health)
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 SWOT Analysis
14.3.11 NTP Radioisotopes SOC Ltd
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.12 PharmaLogic Holdings Corp.
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.13 Siemens AG
14.3.13.1 Company Overview
14.3.13.2 Product Portfolio
14.3.13.3 Financials
14.3.13.4 SWOT Analysis
List of Figures
Figure 1: Global: Radiopharmaceuticals Market: Major Drivers and Challenges
Figure 2: Global: Radiopharmaceuticals Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Radiopharmaceuticals Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Radiopharmaceuticals Market: Breakup by Product Type (in %), 2021
Figure 5: Global: Radiopharmaceuticals Market: Breakup by Application (in %), 2021
Figure 6: Global: Radiopharmaceuticals Market: Breakup by End Use (in %), 2021
Figure 7: Global: Radiopharmaceuticals Market: Breakup by Region (in %), 2021
Figure 8: Global: Radiopharmaceuticals (Diagnostic Nuclear Medicine) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Radiopharmaceuticals (Diagnostic Nuclear Medicine) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Radiopharmaceuticals (Therapeutic Nuclear Medicine) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Radiopharmaceuticals (Therapeutic Nuclear Medicine) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Radiopharmaceuticals (Oncology) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Radiopharmaceuticals (Oncology) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Radiopharmaceuticals (Cardiology) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Radiopharmaceuticals (Cardiology) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Radiopharmaceuticals (Neurology) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Radiopharmaceuticals (Neurology) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Radiopharmaceuticals (Endocrinology) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Radiopharmaceuticals (Endocrinology) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Radiopharmaceuticals (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Radiopharmaceuticals (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Radiopharmaceuticals (Hospitals and Clinics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Radiopharmaceuticals (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Radiopharmaceuticals (Research Institutes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Radiopharmaceuticals (Research Institutes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Radiopharmaceuticals (Diagnostic Centers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Radiopharmaceuticals (Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: North America: Radiopharmaceuticals Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: North America: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: United States: Radiopharmaceuticals Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: United States: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Canada: Radiopharmaceuticals Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Canada: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Asia-Pacific: Radiopharmaceuticals Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Asia-Pacific: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: China: Radiopharmaceuticals Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: China: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Japan: Radiopharmaceuticals Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Japan: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: India: Radiopharmaceuticals Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: India: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: South Korea: Radiopharmaceuticals Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: South Korea: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Australia: Radiopharmaceuticals Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Australia: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Indonesia: Radiopharmaceuticals Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Indonesia: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Others: Radiopharmaceuticals Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Others: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Europe: Radiopharmaceuticals Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Europe: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Germany: Radiopharmaceuticals Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Germany: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: France: Radiopharmaceuticals Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: France: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: United Kingdom: Radiopharmaceuticals Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: United Kingdom: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Italy: Radiopharmaceuticals Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Italy: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Spain: Radiopharmaceuticals Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Spain: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Russia: Radiopharmaceuticals Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Russia: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Others: Radiopharmaceuticals Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Others: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Latin America: Radiopharmaceuticals Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Latin America: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Brazil: Radiopharmaceuticals Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Brazil: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Mexico: Radiopharmaceuticals Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Mexico: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Others: Radiopharmaceuticals Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Others: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Middle East and Africa: Radiopharmaceuticals Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Middle East and Africa: Radiopharmaceuticals Market: Breakup by Country (in %), 2021
Figure 76: Middle East and Africa: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Global: Radiopharmaceuticals Industry: SWOT Analysis
Figure 78: Global: Radiopharmaceuticals Industry: Value Chain Analysis
Figure 79: Global: Radiopharmaceuticals Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Radiopharmaceuticals Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Radiopharmaceuticals Market Forecast: Breakup by Product Type (in Million US$), 2022-2027
Table 3: Global: Radiopharmaceuticals Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 4: Global: Radiopharmaceuticals Market Forecast: Breakup by End Use (in Million US$), 2022-2027
Table 5: Global: Radiopharmaceuticals Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Radiopharmaceuticals Market: Competitive Structure
Table 7: Global: Radiopharmaceuticals Market: Key Players